New Creek Family Medicine Pllc Family Medicine Medicare: Medicare Enrolled Practice Location: 1234 New Creek Hwy, Keyser, WV 26726 Phone: 304-788-9320 Fax: 304-788-9320 |
Potomac Valley Hospital Internal Medicine And Pulmonology Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 390 Carskadon Ln, Keyser, WV 26726 Phone: 304-788-6655 Fax: 304-788-6082 |
Joy E Cousins D O Co Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 1 Grand Central Park, Suite 2060, Keyser, WV 26726 Phone: 304-788-2280 |
Potomac Valley Hospital Of W Va , Inc Clinic/Center - Rural Health Medicare: Medicare Enrolled Practice Location: 100 Pin Oak Ln Ste 3, Keyser, WV 26726 Phone: 304-597-3790 Fax: 304-597-3564 |
Physician Management Services Of West Virginia Ii, Llc Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 37 Carroll Ave, Keyser, WV 26726 Phone: 888-829-8550 |
Charles D Bess, Md Pc Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 514 New Creek Hwy, Keyser, WV 26726 Phone: 304-788-6462 Fax: 304-788-6555 |
Mountain Rose Family Medicine Inc Family Medicine Medicare: Not Enrolled in Medicare Practice Location: Route 4 Box 104, Keyser, WV 26726 Phone: 304-597-2490 Fax: 304-597-2492 |
West End Medical Pllc Family Medicine Medicare: Medicare Enrolled Practice Location: 164 Parkview Dr, Keyser, WV 26726 Phone: 304-597-2494 Fax: 304-597-2497 |
Saweikis Family Medicine Family Medicine Medicare: Medicare Enrolled Practice Location: 240 New Creek Hwy, Keyser, WV 26726 Phone: 304-788-0400 Fax: 304-788-2750 |
News Archive
ICTS, the patient recruitment and clinical trial services company, has successfully completed the fifth in a series of rheumatology study recruitment efforts for the same sponsor. Using an integrated approach that centered around a study website, social media, geographically initiated keyword search advertising, and also included site enrollment toolkits, the program exceeded the enrollment timelines established by the sponsor.
Rexahn Pharmaceuticals, Inc., a clinical stage pharmaceutical company developing and commercializing potential best in class oncology and CNS therapeutics, today announced that it has submitted an investigational new drug application (IND) to the Food and Drug Administration for a first-in-human study of RX-5902 to treat advanced or metastatic solid tumors.
The exponential growth in the number of people tracking their health through activity monitors and biosensor devices is driving the need for industry standards.
Four-year-old girls are six times more likely to have a Body Mass Index (BMI) of more than 30 than they were 20 years ago and ten-year-olds are five times more likely, according to research published in the April issue of Acta Paediatrica.
› Verified 8 days ago